Brown Advisory’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1M | Sell |
192,973
-93,536
| -33% | -$6.51M | 0.02% | 396 |
|
|
2025
Q4 | $19M | Buy |
286,509
+3,470
| +1% | +$224K | 0.03% | 337 |
|
|
2025
Q3 | $19M | Buy |
283,039
+48,538
| +21% | +$3.84M | 0.02% | 333 |
|
|
2025
Q2 | $20.5M | Sell |
234,501
-27,273
| -10% | -$2.14M | 0.03% | 309 |
|
|
2025
Q1 | $17.9M | Buy |
261,774
+46,454
| +22% | +$3.79M | 0.03% | 322 |
|
|
2024
Q4 | $16.7M | Sell |
215,320
-45,666
| -17% | -$3.38M | 0.02% | 352 |
|
|
2024
Q3 | $17.5M | Sell |
260,986
-144,845
| -36% | -$11.9M | 0.02% | 345 |
|
|
2024
Q2 | $46M | Sell |
405,831
-260
| -0.1% | -$32.9K | 0.06% | 220 |
|
|
2024
Q1 | $56.3M | Buy |
406,091
+5,791
| +1% | +$728K | 0.08% | 195 |
|
|
2023
Q4 | $49.7M | Sell |
400,300
-1,290,630
| -76% | -$132M | 0.07% | 203 |
|
|
2023
Q3 | $158M | Sell |
1,690,930
-639,303
| -27% | -$72.1M | 0.26% | 83 |
|
|
2023
Q2 | $299M | Sell |
2,330,233
-61,747
| -3% | -$7.47M | 0.47% | 55 |
|
|
2023
Q1 | $278M | Sell |
2,391,980
-365,355
| -13% | -$40.9M | 0.47% | 52 |
|
|
2022
Q4 | $312M | Sell |
2,757,335
-300,329
| -10% | -$33M | 0.58% | 45 |
|
|
2022
Q3 | $246M | Sell |
3,057,664
-510,770
| -14% | -$43.3M | 0.48% | 54 |
|
|
2022
Q2 | $266M | Sell |
3,568,434
-1,476,126
| -29% | -$135M | 0.5% | 52 |
|
|
2022
Q1 | $645M | Sell |
5,044,560
-559,816
| -10% | -$61.2M | 0.96% | 24 |
|
|
2021
Q4 | $752M | Buy |
5,604,376
+116,644
| +2% | +$16.8M | 0.93% | 27 |
|
|
2021
Q3 | $750M | Sell |
5,487,732
-920,416
| -14% | -$116M | 1.11% | 21 |
|
|
2021
Q2 | $684M | Buy |
6,408,148
+383,772
| +6% | +$36.9M | 1.03% | 24 |
|
|
2021
Q1 | $541M | Sell |
6,024,376
-232,080
| -4% | -$21.8M | 0.93% | 27 |
|
|
2020
Q4 | $578M | Buy |
6,256,456
+318,664
| +5% | +$28.5M | 1.03% | 28 |
|
|
2020
Q3 | $612M | Sell |
5,937,792
-90,752
| -2% | -$9.48M | 1.26% | 23 |
|
|
2020
Q2 | $611M | Sell |
6,028,544
-1,702,192
| -22% | -$152M | 1.42% | 19 |
|
|
2020
Q1 | $520M | Sell |
7,730,736
-1,655,708
| -18% | -$103M | 1.59% | 16 |
|
|
2019
Q4 | $513M | Sell |
9,386,444
-676,332
| -7% | -$32.1M | 1.3% | 24 |
|
|
2019
Q3 | $375M | Sell |
10,062,776
-653,084
| -6% | -$25.4M | 1.05% | 29 |
|
|
2019
Q2 | $401M | Sell |
10,715,860
-125,840
| -1% | -$3.96M | 1.15% | 26 |
|
|
2019
Q1 | $323M | Sell |
10,841,700
-882,708
| -8% | -$31M | 0.92% | 30 |
|
|
2018
Q4 | $351M | Sell |
11,724,408
-378,688
| -3% | -$12M | 1.18% | 23 |
|
|
2018
Q3 | $433M | Sell |
12,103,096
-618,428
| -5% | -$19.2M | 1.23% | 25 |
|
|
2018
Q2 | $302M | Sell |
12,721,524
-1,621,436
| -11% | -$34.4M | 0.93% | 29 |
|
|
2018
Q1 | $266M | Sell |
14,342,960
-550,780
| -4% | -$8.14M | 0.86% | 35 |
|
|
2017
Q4 | $214M | Sell |
14,893,740
-1,768,348
| -11% | -$23M | 0.68% | 44 |
|
|
2017
Q3 | $204M | Buy |
16,662,088
+6,060,536
| +57% | +$107M | 0.68% | 43 |
|
|
2017
Q2 | $194M | Sell |
10,601,552
-342,016
| -3% | -$6.32M | 0.59% | 47 |
|
|
2017
Q1 | $232M | Sell |
10,943,568
-8,246,056
| -43% | -$161M | 0.79% | 39 |
|
|
2016
Q4 | $286M | Buy |
19,189,624
+4,552,400
| +31% | +$80.6M | 1.02% | 31 |
|
|
2016
Q3 | $321M | Buy |
14,637,224
+14,626,980
| +142,786% | +$326M | 1.1% | 27 |
|
|
2016
Q2 | $204K | Buy |
+10,244
| New | +$174K | ﹤0.01% | 979 |
|
Other funds holding DXCM
VCM
VPM
Brown Advisory's DXCM Position: Q1 2026 in Review
Brown Advisory reduced its DexCom (DXCM) stake by 33% in Q1 2026, selling an estimated $6.51M and leaving 192,973 shares worth $12.1M. The position accounts for 0.02% of the portfolio, ranked #396.
Brown Advisory first reported a position in DXCM in Q2 2016 and has held it in 40 quarters since. The position peaked at $752M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Brown Advisory held 192,973 shares of DexCom worth $12.1M as of Q1 2026.
- Brown Advisory sold 93,536 DexCom shares in Q1 2026, an estimated $6.51M.
- DexCom made up 0.02% of Brown Advisory's portfolio in Q1 2026, its #396 holding.
- Brown Advisory first reported a position in DexCom in Q2 2016 and has held it in 40 quarters since.
- Brown Advisory's DexCom position peaked at $752M in Q4 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.